Comparison of Intubation With Nerve Block and With Sedation in Awake Patients
NCT ID: NCT01768377
Last Updated: 2013-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
70 participants
INTERVENTIONAL
2012-11-30
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sedation Compaired With Anesthesia With THRIVE in Endotracheal Intubation With Difficult Airways
NCT04924621
Comparing Conscious Sedation to Retrobulbar Block Anesthetics During Trans-scleral Diode Laser
NCT03646500
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
NCT06601036
Comparison of Total Intravenous Anesthesia vs. Inhalational Anesthesia in Acute Subdural Hematoma Patients
NCT03146104
Three Anaesthesic Method in Electroconvulsive Theraphy
NCT01759589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intubation with sedation
Sedation with midazolam and analgesia with fentanyl
Fentanyl
Fentanyl 2 microgram/Kg BW IV
Midazolam
Midazolam 0.05 mg/kg BW IV infusion
Intubation with Nerve block
Laryngeal plus supraglottic plus intratracheal nerve block plus sedation with midazolam
Nerve block with Lidocain
Lidocain 2% topical injection, 0.5 - 1 cc Lidocain 4% topical injection, 3 cc Lidocain 10% topical spray , total dose 50 mg
Midazolam
Midazolam 0.05 mg/kg BW IV infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nerve block with Lidocain
Lidocain 2% topical injection, 0.5 - 1 cc Lidocain 4% topical injection, 3 cc Lidocain 10% topical spray , total dose 50 mg
Fentanyl
Fentanyl 2 microgram/Kg BW IV
Midazolam
Midazolam 0.05 mg/kg BW IV infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age\>= 18 years
* Patient or patient's guardian's consent
Exclusion Criteria
* Allergy to Lidocain in block group
* Allergy to opioid drugs in sedation group
* Allergy to midazolam in either group
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tehran University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammad Jalili, MD
Role: STUDY_DIRECTOR
TUMS
Amir Nejati, MD
Role: PRINCIPAL_INVESTIGATOR
TUMS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imam Khomeini Hospital
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
130-1928
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.